BioSpace News Archive

LEXEO Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for LX2006.

Mydecine Innovations Group Inc. today announced the inclusion of a novel molecule with potentially heart-safe microdose enabling properties in their family of psilocin analogs.

Cytokinetics, Incorporated (Nasdaq: CYTK) and the American Heart Association (AHA) Bay Area today announced a three-year collaboration to accelerate education and awareness of heart disease.

Over the past decade, neurointerventional techniques have gained increased significance in the management of acute ischemic strokes.

Typical ENT disorders include cholesteatoma, dizziness, dysphagia (difficulty swallowing), ear infection (otitis media), gastric reflux, hearing aids, and hearing loss.

Cyclotron is a class of devices that accelerates charged atomic or subatomic particles in a constant magnetic field.

Biohaven Pharmaceutical Holding Company Ltd. will hold its upcoming fourth quarter and year end 2021 earnings call and webcast, reporting financial results for the quarter ended December 31, 2021 and provide a review of recent accomplishments and anticipated upcoming milestones, on Friday February 25, 2022 at 8:30 a.m. ET.

Our immune systems have the potential to find and destroy cancer cells. But cancer cells can be clever and develop tricks to evade the immune system.